These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7647820)

  • 1. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.
    Swinburn BA; Carmichael HE; Wilson MR
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1033-40. PubMed ID: 8923161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexfenfluramine reduces cardiovascular risk factors.
    Bremer JM; Scott RS; Lintott CJ
    Int J Obes Relat Metab Disord; 1994 Apr; 18(4):199-205. PubMed ID: 8044193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour.
    Mathus-Vliegen EM; van de Voorde K; Kok AM; Res AM
    J Intern Med; 1992 Aug; 232(2):119-27. PubMed ID: 1506807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial.
    Andersen T; Astrup A; Quaade F
    Int J Obes Relat Metab Disord; 1992 Jan; 16(1):35-40. PubMed ID: 1314242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
    Lafreniere F; Lambert J; Rasio E; Serri O
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):25-30. PubMed ID: 8383638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dexfenfluramine and feeding behavior. Clinical and pharmacoclinical studies].
    Fantino M
    Ann Med Interne (Paris); 1989; 140 Suppl 1():12-6. PubMed ID: 2672935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible thermogenesis with dexfenfluramine.
    Roongpisuthipong C; Panpakdee O; Boontawee A; Kulapongse S; Tanphaichitr V
    J Med Assoc Thai; 1999 Feb; 82(2):150-9. PubMed ID: 10087722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexfenfluramine, fluoxetine, and weight loss among female carbohydrate cravers.
    Wurtman J; Wurtman R; Berry E; Gleason R; Goldberg H; McDermott J; Kahne M; Tsay R
    Neuropsychopharmacology; 1993 Nov; 9(3):201-10. PubMed ID: 8280344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dexfenfluramine in a weight loss program for obese infertile women.
    Galletly C; Clark A; Tomlinson L
    Int J Eat Disord; 1996 Mar; 19(2):209-12. PubMed ID: 8932560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized evaluation of a low fat ad libitum carbohydrate diet for weight reduction.
    Schlundt DG; Hill JO; Pope-Cordle J; Arnold D; Virts KL; Katahn M
    Int J Obes Relat Metab Disord; 1993 Nov; 17(11):623-9. PubMed ID: 8281220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotoninergic drug-induced weight loss in carbohydrate craving obese patients.
    Toornvliet AC; Pijl H; Hopman E; Elte-de Wever BM; Meinders AE
    Int J Obes Relat Metab Disord; 1996 Oct; 20(10):917-20. PubMed ID: 8910095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexfenfluramine influences dietary compliance and eating behavior, but dietary instruction may overrule its effect on food selection in obese subjects.
    Mathus-Vliegen LM; Res AM
    J Am Diet Assoc; 1993 Oct; 93(10):1163-5. PubMed ID: 8409140
    [No Abstract]   [Full Text] [Related]  

  • 16. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.
    Chow CC; Ko GT; Tsang LW; Yeung VT; Chan JC; Cockram CS
    Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almonds vs complex carbohydrates in a weight reduction program.
    Wien MA; Sabaté JM; Iklé DN; Cole SE; Kandeel FR
    Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1365-72. PubMed ID: 14574348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of dexfenfluramine on amino acid profiles and food selection in obese patients during weight loss.
    Breum L; Møller SE; Andersen T; Astrup A
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):147-53. PubMed ID: 8646251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of dietary recall using the USDA five-step multiple-pass method in men: an observational validation study.
    Conway JM; Ingwersen LA; Moshfegh AJ
    J Am Diet Assoc; 2004 Apr; 104(4):595-603. PubMed ID: 15054345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexfenfluramine and appetite in humans.
    Blundell JE; Hill AJ
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S51-9. PubMed ID: 1338323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.